Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?

Literature DB >> 26077840

Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?

Finn Sellebjerg¹, Annette Bang Oturai¹.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2015 PMID： 26077840 DOI： 10.1038/nrneurol.2015.103

Source DB: PubMed Journal: Nat Rev Neurol ISSN： 1759-4758 Impact factor: 42.937

× No keyword cloud information.

10 in total

Review 1. Organellar Na+/H+ exchangers: novel players in organelle pH regulation and their emerging functions.

Authors: Ryuichi Ohgaki; Sven C D van IJzendoorn; Masafumi Matsushita; Dick Hoekstra; Hiroshi Kanazawa
Journal: Biochemistry Date: 2010-12-30 Impact factor: 3.162

Review 2. Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis.

Authors: Richard A Rudick; Chris H Polman
Journal: Lancet Neurol Date: 2009-06 Impact factor: 44.182

Review 3. New management algorithms in multiple sclerosis.

Authors: Per Soelberg Sorensen
Journal: Curr Opin Neurol Date: 2014-06 Impact factor: 5.710

4. Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis.

Authors: Manuel Comabella; David W Craig; Carlos Morcillo-Suárez; Jordi Río; Arcadi Navarro; Marta Fernández; Roland Martin; Xavier Montalban
Journal: Arch Neurol Date: 2009-08

5. An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity.

Authors: Linda Ottoboni; Brendan T Keenan; Pablo Tamayo; Manik Kuchroo; Jill P Mesirov; Guy J Buckle; Samia J Khoury; David A Hafler; Howard L Weiner; Philip L De Jager
Journal: Sci Transl Med Date: 2012-09-26 Impact factor: 17.956

6. Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults.

Authors: Jennifer E Huffman; Ana Knezevic; Veronique Vitart; Jayesh Kattla; Barbara Adamczyk; Mislav Novokmet; Wilmar Igl; Maja Pucic; Lina Zgaga; Åsa Johannson; Irma Redzic; Olga Gornik; Tatijana Zemunik; Ozren Polasek; Ivana Kolcic; Marina Pehlic; Carolien A M Koeleman; Susan Campbell; Sarah H Wild; Nicholas D Hastie; Harry Campbell; Ulf Gyllensten; Manfred Wuhrer; James F Wilson; Caroline Hayward; Igor Rudan; Pauline M Rudd; Alan F Wright; Gordan Lauc
Journal: Hum Mol Genet Date: 2011-09-09 Impact factor: 6.150

7. A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity.

Authors: Federica Esposito; Melissa Sorosina; Linda Ottoboni; Elaine T Lim; Joseph M Replogle; Towfique Raj; Paola Brambilla; Giuseppe Liberatore; Clara Guaschino; Marzia Romeo; Thomas Pertel; James M Stankiewicz; Vittorio Martinelli; Mariaemma Rodegher; Howard L Weiner; David Brassat; Christophe Benoist; Nikolaos A Patsopoulos; Giancarlo Comi; Wassim Elyaman; Filippo Martinelli Boneschi; Philip L De Jager
Journal: Ann Neurol Date: 2015-05-14 Impact factor: 10.422

1 in total

Review 1. Protons to Patients: targeting endosomal Na⁺ /H⁺ exchangers against COVID-19 and other viral diseases.

Authors: Hari Prasad
Journal: FEBS J Date: 2021-09 Impact factor: 5.622

1 in total

Multiple sclerosis: A clinically useful genetic variant in multiple sclerosis?

Review 1. Organellar Na+/H+ exchangers: novel players in organelle pH regulation and their emerging functions.

Review 2. Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis.

Review 3. New management algorithms in multiple sclerosis.

4. Genome-wide scan of 500,000 single-nucleotide polymorphisms among responders and nonresponders to interferon beta therapy in multiple sclerosis.

5. An RNA profile identifies two subsets of multiple sclerosis patients differing in disease activity.

6. Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults.

7. A pharmacogenetic study implicates SLC9a9 in multiple sclerosis disease activity.

8. Genome-wide pharmacogenomic analysis of the response to interferon beta therapy in multiple sclerosis.

9. Prediction of response to interferon therapy in multiple sclerosis.

10. Multiple sclerosis pharmacogenomics: maximizing efficacy of therapy.

Review 1. Protons to Patients: targeting endosomal Na⁺ /H⁺ exchangers against COVID-19 and other viral diseases.

Review 1. Organellar Na+/H+ exchangers: novel players in organelle pH regulation and their emerging functions.

Review 2. Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis.

Review 3. New management algorithms in multiple sclerosis.

Review 1. Protons to Patients: targeting endosomal Na+ /H+ exchangers against COVID-19 and other viral diseases.

Review 1. Protons to Patients: targeting endosomal Na⁺ /H⁺ exchangers against COVID-19 and other viral diseases.